ATF4 and hepatocellular carcinoma: Current evidence suggests that S-HBsAg activates the FGF19-JAK2-STAT3 pathway through the ATF4 pathway, causing the epithelial-mesenchymal transition of hepatocytes, which can promote the occurrence of hepatocellular carcinoma [77].